Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Enterococcus faecalis (CL 8516 + vancomycin-susceptible) |
- |
- |
>32 - ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1072 |
Enterococcus faecalis (CL 8516 + vancomycin-susceptible) |
- |
- |
64 - ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
1072 |
Enterococcus faecalis (CL8516) |
- |
- |
≤0.015 - ? |
Philipimycin |
1270 |
Enterococcus faecalis (clindamycin-intermediate-susceptible) |
≤0.12 |
≤0.12 |
? - ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
Enterococcus faecalis (clindamycin-resistant) |
0.12 |
2 |
? - ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
Enterococcus faecalis (clinical isolate) |
- |
- |
7.38 - ? |
Chlorhexidine |
1368 |
Enterococcus faecalis (D2HT6) |
- |
- |
0.6 - ? |
Eperezolid (PNU-100592) |
11 |
Enterococcus faecalis (D2HT6) |
- |
- |
0.6 - ? |
RU79115 |
33 |
Enterococcus faecalis (D2HT6) |
- |
- |
2.5 - ? |
Vancomycin (Vancocyn, Lyphocin) |
33 |
Enterococcus faecalis (EFS008) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
224 |
Enterococcus faecalis (EFS008) |
- |
- |
4 - ? |
Vancomycin (Vancocyn, Lyphocin) |
224 |
Enterococcus faecalis (endodontic isolate) |
- |
- |
27.5 - ? |
Garlic (Essential oil) (Allicin) |
262 |
Enterococcus faecalis (ENT11U + vancomycin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
193 |
Enterococcus faecalis (ENT11U + vancomycin-resistant) |
- |
- |
2 - ? |
PH-027 |
193 |
Enterococcus faecalis (ENT11U + vancomycin-resistant) |
- |
- |
>32 - ? |
Vancomycin (Vancocyn, Lyphocin) |
193 |
Enterococcus faecalis (ENT90 + vancomycin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
193 |
Enterococcus faecalis (ENT90 + vancomycin-resistant) |
- |
- |
2 - ? |
PH-027 |
193 |
Enterococcus faecalis (ENT90 + vancomycin-resistant) |
- |
- |
>32 - ? |
Vancomycin (Vancocyn, Lyphocin) |
193 |
Enterococcus faecalis (erythromycin-intermediate-susceptible) |
≤0.12 |
≤0.12 |
? - ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
Enterococcus faecalis (erythromycin-resistant + vancomycin-susceptible) |
1 |
4 |
0.015 - 8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
448 |
Enterococcus faecalis (erythromycin-resistant + vancomycin-susceptible) |
2 |
16 |
0.007 - 64 |
HMR 3004 (RU 64004) |
448 |
Enterococcus faecalis (erythromycin-resistant + vancomycin-susceptible) |
32 |
64 |
2 - >64 |
Quinupristin/Dalfopristin (Synercid) |
448 |
Enterococcus faecalis (erythromycin-resistant + vancomycin-susceptible) |
>256 |
>256 |
16 - >256 |
Clindamycin (Cleocin) |
448 |
Enterococcus faecalis (erythromycin-resistant + vancomycin-susceptible) |
>512 |
>512 |
1 - >512 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
448 |
Enterococcus faecalis (erythromycin-resistant) |
0.25 |
4 |
? - ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
Enterococcus faecalis (erythromycin-susceptible + vancomycin-susceptible) |
0.015 |
0.015 |
0.015 - 0.03 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
448 |
Enterococcus faecalis (erythromycin-susceptible + vancomycin-susceptible) |
0.015 |
0.015 |
0.015 - ? |
HMR 3004 (RU 64004) |
448 |
Enterococcus faecalis (erythromycin-susceptible + vancomycin-susceptible) |
0.06 |
0.5 |
0.06 - 0.5 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
448 |